ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

1985 International Cancer Congress to Be In Budapest

September 24, 1982

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007

Higher Tobacco Tax Will Save Lives, Groups Tell Clinton, congress

January 22, 1993

NSABP Donates Sculpture to NIH to Commemorate 50th Year.

September 19, 2008

Study Finds Green Tea No Help In Advanced Prostate Cancer

March 28, 2003

ACS Seeks Applications For Clinical Awards

January 1, 1993